Concepedia

Beate C. Litzenburger

BC

Statistics

Publications

16

Citations

773

H-Index

13

Active since

2007

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Baylor College of Medicine

UPMC Hillman Cancer Center

Bristol-Myers Squibb (United States)

Beate C. Litzenburger is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2007–2020

16

Publications

16

Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail

Hyun Jung Kim, Beate C. Litzenburger, Xiaojiang Cui et al. · Molecular and Cellular Biology · 2007 · 247 citations · Full text

, , +17

High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy

Beate C. Litzenburger, Chad J. Creighton, Anna Tsimelzon et al. · Clinical Cancer Research · 2010 · 131 citations · Full text

, , +11

The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform

Amber M. Johnson, Jia Zeng, Ann M. Bailey et al. · Drug Discovery Today · 2015 · 73 citations

, , +16

BMS-536924 Reverses IGF-IR-Induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells

Beate C. Litzenburger, Hyun-Jung Kim, Isere Kuiatse et al. · Clinical Cancer Research · 2008 · 59 citations · Full text

, , +13

“Personalized Cancer Therapy”: A Publicly Available Precision Oncology Resource

Katherine C. Kurnit, Ann M. Bailey, Jia Zeng et al. · Cancer Research · 2017 · 46 citations · Full text

, , +17

1–5 of 16